Advisor Group Holdings, Inc. Mustang Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.46 - $7.2 $9,142 - $143,100	-19,875 Reduced 78.54%	5,431 $3,000
Q2 2022 Aug 10, 2022	BUY	$0.58 - $1.13 $3,331 - $6,490	5,744 Added 29.36%	25,306 $15,000
Q1 2022 May 04, 2022	BUY	$0.73 - $1.81 $7,858 - $19,484	10,765 Added 122.37%	19,562 $19,000
Q3 2021 Nov 05, 2021	BUY	$2.58 - $3.36 $2,732 - $3,558	1,059 Added 13.69%	8,797 $23,000
Q2 2021 Aug 02, 2021	BUY	$2.7 - $3.81 $6,061 - $8,553	2,245 Added 40.87%	7,738 $26,000
Q1 2021 May 13, 2021	BUY	$3.02 - $5.16 $4,010 - $6,852	1,328 Added 31.88%	5,493 $19,000
Q4 2020 Feb 10, 2021	BUY	$2.66 - $4.18 $8,152 - $12,811	3,065 Added 278.64%	4,165 $16,000
Q3 2020 Nov 12, 2020	BUY	$3.01 - $3.88 $3,010 - $3,880	1,000 Added 1000.0%	1,100 $3,000
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $233 - $459	100 New	100 $0

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.